Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...

This November, the nonprofit I AM ALS is launching a peer support program as part of its new campaign focused on supporting ...

Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS ...

The condition is a rapidly progressive neurodegenerative disorder leading to wasting, paralysis, and eventual death from ...

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...

A funding boost of more than £78 million will help UCL scientists working to develop a potential treatment for motor neurone ...

Amyotrophic lateral sclerosis (ALS) is the most common form of MND and there is currently no cure for the condition which ...

Scientists have identified a relationship between ancient viral DNA and susceptibility to neurodegenerative diseases like ...

Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS), an incurable degenerative ... almost all of which affect neuromuscular ...

Trace Neuroscience's lead program is an antisense oligonucleotide (ASO) designed to preserve and potentially improve muscle function in people living with amyotrophic lateral sclerosis (ALS), ...